mDPR-Val-Cit-PAB-MMAE TFA is a drug-linker conjugate for ADC, combining MMAE, a tubulin polymerization inhibitor, with a protease-sensitive Val-Cit peptide. It targets cancer cells by attaching to monoclonal antibodies, delivering the MMAE anticancer payload. The maleimide moiety can react with cysteine or other thiol molecule for bioconjugation.
Products > PEG Linkers > GGFG Linkers | Products > ADC Linker, ADC Payload > Cleavable Linkers > Val-Cit-MMAE | Products > ADC Linker, ADC Payload > ADC Payload > MMAE
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.